Avignon, January 7th, 2013
Pursuant to the liquidity contract granted to NATIXIS regarding NATUREX shares, the following elements were in the liquidity account as of December 31st, 2012:2,357 NATUREX shares 601,658.69 euros
The following elements appeared on the liquidity account as of June 30th, 2012:12,028 NATUREX shares 106,273.45 euros
For information, the following elements appeared on the liquidity account at the time of the implementation of the liquidity contract:923 NATUREX shares 277,801.85 euros
Download our press releases and other publications on www.naturex.com
Naturex has been listed on NYSE Euronext Paris, Compartment B (Mid Caps), since October 1996.
|Total number of shares comprising the share capital: 7,728,539
Naturex is a component of the CAC Small and Gaïa indexes.
Naturex is eligible for "long only" Deferred Settlement Service (SRD).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.
SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY
Naturex is the global leader in speciality plant-based natural ingredients.
The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs more than 1,300 people with high-performance manufacturing operations across 15 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland) as well as in Morocco, the United States, Brazil, Australia and India. It also has a global presence through a dedicated network of sales offices in 21 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Singapore, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).
Naturex's development is supported by positive underlying trends linked to the fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.
Chairman and Chief Executive Officer
Tel: +33 (0)4 90 23 96 89
|Thierry Bertrand Lambert
Chief Financial Officer
Tel: +33 (0)4 90 23 96 89
Tel: +33 (0)4 90 23 78 28
Anne Catherine Bonjour
Actus Finance Press Relations
Tel: +33 (0)1 53 67 36 93
Rachat d'actions / contrat de liquidité :
- Information relative au contrat de liquidité Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-30551-2013.01.07-summary-of-liquidity-contract-december-2012.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
|NATUREX||Euronext Paris||83.30 (c)||0.18%||4 738|